Key result
Personalised pulmonary rehabilitation improves daily symptoms, exercise performance, and health status in patients with COPD, though direct demonstration of a survival benefit is lacking.
Personalised pulmonary rehabilitation is recognized as a fundamental part of integrated care for COPD patients, improving daily symptoms, exercise performance, and health status.
Personalised pulmonary rehabilitation with multidimensional response profiling could aid efficiency and effectiveness <http://ow.ly/TouTt> Clinical practice should be based on the best scientific evidence, which does not always correspond to evidence-based medicine, involving guidelines, meta-analyses and protocols as a basis for clinical approach [1, 2]. There is no need of further randomised controlled trials (RCTs) for evidence that pulmonary rehabilitation (PR) improves daily symptoms, exercise performance and health status in patients with chronic obstructive pulmonary disease (COPD), independently of disease stage and complexity [3]. Although the direct demonstration of a clear benefit in survival is lacking (as is also true for most therapies used in COPD), PR is well recognised as a fundamental part of the integrated care of these patients and it has been incorporated in most guidelines for their management [4].
No takes yet. Share an insight, caveat, or question.
Ambrosino et al. (2015) conducted an editorial in Chronic obstructive pulmonary disease (COPD). Personalised pulmonary rehabilitation was evaluated. Personalised pulmonary rehabilitation improves daily symptoms, exercise performance, and health status in patients with COPD, though direct demonstration of a survival benefit is lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: